S. Aliberti (Milan, Italy), S. Ewig (Bochum, Germany)
Symptoms of chronic bronchitis have decreased among Finnish men during 40 years
P. Jousilahti, T. Laatikainen, T. Haahtela, E. Vartiainen (Helsinki, Finland)
|  |
Alteration of the immune response to streptococcus pneumoniae during COPD exacerbation in mice
M. Pichavant, G. Rémy, G. Kervoaze, R. Sharan, E. Vilain, P. Gosset (Lille, France)
| |
Severity-related microbiome changes in COPD
M. Garcia-Nuñez, L. Millares, V. Perez-Brocal, R. Ferrari, M. Gallego, C. Monton, J. Pomares, M. Espasa, A. Mira, A. Moya, E. Monso (Sabadell, Bunyola (Mallorca), Valencia, Spain)
| |
Impact of chronic obstructive pulmonary disease in the outcome of intensive care unit-acquired pneumonia
M. Rinaudo, M. Ferrer, H. Loureiro, R. Peralta, S. Terraneo, F. De Rosa, G. Li Bassi, A. Torres (Barcelona, Spain; Milan, Italy)
|  |
Eosinophilia as marker of outcome in hospitalised patients with AECOPD
H. J. Prins, D. Snijders, J. M. A. Daniels, W. G. Boersma (ALkmaar, Amsterdam, Netherlands)
|  |
COPD as risk factor for mortality in CAP. Results from the German Competence Network, CAPNETZ
D. Braeken, F. Franssen, H. Schütte, M. Pletz, R. Bals, G. Rohde (Horn, Maastricht, Netherlands; Berlin, Jena, Homburg, Germany)
| |
T cell exhaustion marker expression in the human lung in health and COPD in response to influenza infection
R. McKendry, C. Spalluto, B. Nicholas, K. Staples, T. Wilkinson (Southampton, United Kingdom)
| |
Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method
S. Minezaki, H. Nakamura, T. Hirama, A. Shiono, A. Kawashima, M. Nagata, K. Hagiwara, M. Kanazawa (Moroyama-machi, Japan)
| |